Article Details
Retrieved on: 2022-10-06 16:18:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Earlier this year, the CMS extended that limitation to all monoclonal antibodies used to treat AD. Lecanemab, a monoclonal antibody, showed the ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here